InvestWiser

RaySearch Laboratories AB (publ)

RAY-BNasdaq StockholmHealthcareMarket value 5.1 bn SEK
171.90SEK −1.4%
last day · Price as of 18 November 2026

The answer first

Does RaySearch Laboratories beat the market?

No, RaySearch Laboratories has not beaten the market over the last year.

RaySearch Laboratories−20.4%Stockholm (OMXSGI)+17.6%
  • The ranking · Quality, value and trend combined

    Better than 29% of Nordic stocks

    • Quality77
    • Value17
    • Trend29

    No. 106 of 195 in healthcare

  • Expectations in the price

    Low expectations

    For the share to return about 9% a year from today's price, the cash RaySearch Laboratories keeps must grow about 2% a year for 10 years.

Max for seven days

Follow RaySearch Laboratories with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on RaySearch Laboratories

From today, at a price of 171.90 SEK. Write why you follow RaySearch Laboratories, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about RaySearch Laboratories

Your first answer is free, no account needed.

Do you own RaySearch Laboratories, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with RaySearch Laboratories and a few more. Free, no card.

Past year against the exchange and Super Stock
RaySearch Laboratories−20.4%Stockholm (OMXSGI)+17.6%Super Stock+44.6%
17 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • RaySearch Laboratories has fallen 20.4% over the past year, including dividends.
  • Overall, RaySearch Laboratories ranks better than 29% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 54.1%. The price is 52.0% below its peak now.

Who owns RaySearch Laboratories? See the major shareholders and their stakes

What do analysts think of RaySearch Laboratories?

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

29

Quality, value and trend together. Better than 29% of Nordic stocks.

No. 106 of 195 in healthcare

Quality77
The company · Fundamentals: the accounts

High A solid company: it earns well on its money and has healthy finances.

No. 63 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity1.00
  • Asset turnoverSales divided by everything the company owns0.73
  • Return on equityProfit divided by equity+25.4%
  • Cash conversionOperating cash flow divided by profit2.08

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value17
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 109 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50

  • P/BPrice divided by equity7.0
  • P/SPrice divided by sales4.2
  • P/EPrice divided by earnings27.6
  • P/CFPrice divided by operating cash flow13.3

The ranking is built on P/E, P/B and P/S.

Trend29
The share price · Technical: the price trend

Low Headwind in the share price: it has done worse than most over the last year.

No. 106 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−6.3%
  • 6 months−21.4%
  • 9 months−7.6%
  • 12 months−20.4%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−11.6%
3 years, per year
+26.4%
5 years, per year
+22.2%
10 years, per year
−0.6%
Largest fall, 3 years
−54.1%
From a peak to the bottom
From the peak now
−52.0%
How far the price is from the peak
Volatility, 1 year
45.8%
How much the price swings over a year
Beta, 1 year
0.94
How much the price moves when the market moves

Return with dividends reinvested.

The funds that own RaySearch Laboratories

24 funds we follow own RaySearch Laboratories. The share is how much of the fund the stock makes up.

  • Norway1
  • Sweden23
  • 1 ETF

From the funds' latest known holdings.

About RaySearch Laboratories

RaySearch Laboratories AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 480 employees.

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems.

See the full analysis of RaySearch Laboratories.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market